USA Point-of-care Infectious Disease Diagnostics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Point-of-care Infectious Disease Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Point-of-care Infectious Disease Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Point-of-care Infectious Disease Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Trinity Biotech

    • MedMira

    • Sekisui Diagnostics

    • Alere

    • Chembio Diagnostic Systems

    • Thermo Fisher Scientific

    • OraSure Technologies

    • Calypte Biomedical

    • Quidel

    • Meridian Bioscience

    By Type:

    • HIV POC

    • Clostridium Difficile POC

    • HBV POC

    • Respiratory Syncytial Virus POC

    • HPV POC

    • Influenza/Flu POC

    • HCV POC

    • MRSA POC

    • TB and Drug-Resistant TB POC

    By End-User:

    • Hospitals

    • Clinics

    • Home

    • Assisted Living Healthcare Facilities

    • Laboratories

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Point-of-care Infectious Disease Diagnostics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HIV POC from 2016 to 2027

      • 1.3.2 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clostridium Difficile POC from 2016 to 2027

      • 1.3.3 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HBV POC from 2016 to 2027

      • 1.3.4 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Respiratory Syncytial Virus POC from 2016 to 2027

      • 1.3.5 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HPV POC from 2016 to 2027

      • 1.3.6 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Influenza/Flu POC from 2016 to 2027

      • 1.3.7 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HCV POC from 2016 to 2027

      • 1.3.8 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of MRSA POC from 2016 to 2027

      • 1.3.9 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of TB and Drug-Resistant TB POC from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clinics from 2016 to 2027

      • 1.4.3 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Home from 2016 to 2027

      • 1.4.4 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Assisted Living Healthcare Facilities from 2016 to 2027

      • 1.4.5 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Laboratories from 2016 to 2027

      • 1.4.6 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Point-of-care Infectious Disease Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Point-of-care Infectious Disease Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of HIV POC

      • 3.4.2 Market Size and Growth Rate of Clostridium Difficile POC

      • 3.4.3 Market Size and Growth Rate of HBV POC

      • 3.4.4 Market Size and Growth Rate of Respiratory Syncytial Virus POC

      • 3.4.5 Market Size and Growth Rate of HPV POC

      • 3.4.6 Market Size and Growth Rate of Influenza/Flu POC

      • 3.4.7 Market Size and Growth Rate of HCV POC

      • 3.4.8 Market Size and Growth Rate of MRSA POC

      • 3.4.9 Market Size and Growth Rate of TB and Drug-Resistant TB POC

    4 Segmentation of Point-of-care Infectious Disease Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Point-of-care Infectious Disease Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Hospitals

      • 4.4.2 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Clinics

      • 4.4.3 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Home

      • 4.4.4 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Assisted Living Healthcare Facilities

      • 4.4.5 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Laboratories

      • 4.4.6 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Others

    5 Market Analysis by Regions

    • 5.1 USA Point-of-care Infectious Disease Diagnostics Production Analysis by Regions

    • 5.2 USA Point-of-care Infectious Disease Diagnostics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis

    • 6.1 West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types

    • 6.2 West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users

    7 South USA Point-of-care Infectious Disease Diagnostics Landscape Analysis

    • 7.1 South USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types

    • 7.2 South USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users

    8 Middle West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis

    • 8.1 Middle West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types

    • 8.2 Middle West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users

    9 Northeast USA Point-of-care Infectious Disease Diagnostics Landscape Analysis

    • 9.1 Northeast USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types

    • 9.2 Northeast USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Trinity Biotech

        • 10.1.1 Trinity Biotech Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 MedMira

        • 10.2.1 MedMira Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Sekisui Diagnostics

        • 10.3.1 Sekisui Diagnostics Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Alere

        • 10.4.1 Alere Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Chembio Diagnostic Systems

        • 10.5.1 Chembio Diagnostic Systems Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Thermo Fisher Scientific

        • 10.6.1 Thermo Fisher Scientific Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 OraSure Technologies

        • 10.7.1 OraSure Technologies Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Calypte Biomedical

        • 10.8.1 Calypte Biomedical Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Quidel

        • 10.9.1 Quidel Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Meridian Bioscience

        • 10.10.1 Meridian Bioscience Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HIV POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clostridium Difficile POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HBV POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Respiratory Syncytial Virus POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HPV POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Influenza/Flu POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HCV POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of MRSA POC from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of TB and Drug-Resistant TB POC from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clinics from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Home from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Assisted Living Healthcare Facilities from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Laboratories from 2016 to 2027

    • Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Point-of-care Infectious Disease Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Point-of-care Infectious Disease Diagnostics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Point-of-care Infectious Disease Diagnostics by Different Types from 2016 to 2027

    • Table Consumption Share of Point-of-care Infectious Disease Diagnostics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of HIV POC

    • Figure Market Size and Growth Rate of Clostridium Difficile POC

    • Figure Market Size and Growth Rate of HBV POC

    • Figure Market Size and Growth Rate of Respiratory Syncytial Virus POC

    • Figure Market Size and Growth Rate of HPV POC

    • Figure Market Size and Growth Rate of Influenza/Flu POC

    • Figure Market Size and Growth Rate of HCV POC

    • Figure Market Size and Growth Rate of MRSA POC

    • Figure Market Size and Growth Rate of TB and Drug-Resistant TB POC

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Point-of-care Infectious Disease Diagnostics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Point-of-care Infectious Disease Diagnostics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Home

    • Figure Market Size and Growth Rate of Assisted Living Healthcare Facilities

    • Figure Market Size and Growth Rate of Laboratories

    • Figure Market Size and Growth Rate of Others

    • Table USA Point-of-care Infectious Disease Diagnostics Production by Regions

    • Table USA Point-of-care Infectious Disease Diagnostics Production Share by Regions

    • Figure USA Point-of-care Infectious Disease Diagnostics Production Share by Regions in 2016

    • Figure USA Point-of-care Infectious Disease Diagnostics Production Share by Regions in 2021

    • Figure USA Point-of-care Infectious Disease Diagnostics Production Share by Regions in 2027

    • Table USA Point-of-care Infectious Disease Diagnostics Consumption by Regions

    • Table USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions

    • Figure USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions in 2016

    • Figure USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions in 2021

    • Figure USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions in 2027

    • Table West USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027

    • Table West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027

    • Table West USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027

    • Table West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021

    • Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027

    • Table South USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027

    • Table South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027

    • Table South USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027

    • Table South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021

    • Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027

    • Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027

    • Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027

    • Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021

    • Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027

    • Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027

    • Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027

    • Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021

    • Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Trinity Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trinity Biotech

    • Figure Sales and Growth Rate Analysis of Trinity Biotech

    • Figure Revenue and Market Share Analysis of Trinity Biotech

    • Table Product and Service Introduction of Trinity Biotech

    • Table Company Profile and Development Status of MedMira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedMira

    • Figure Sales and Growth Rate Analysis of MedMira

    • Figure Revenue and Market Share Analysis of MedMira

    • Table Product and Service Introduction of MedMira

    • Table Company Profile and Development Status of Sekisui Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sekisui Diagnostics

    • Figure Sales and Growth Rate Analysis of Sekisui Diagnostics

    • Figure Revenue and Market Share Analysis of Sekisui Diagnostics

    • Table Product and Service Introduction of Sekisui Diagnostics

    • Table Company Profile and Development Status of Alere

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere

    • Figure Sales and Growth Rate Analysis of Alere

    • Figure Revenue and Market Share Analysis of Alere

    • Table Product and Service Introduction of Alere

    • Table Company Profile and Development Status of Chembio Diagnostic Systems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chembio Diagnostic Systems

    • Figure Sales and Growth Rate Analysis of Chembio Diagnostic Systems

    • Figure Revenue and Market Share Analysis of Chembio Diagnostic Systems

    • Table Product and Service Introduction of Chembio Diagnostic Systems

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of OraSure Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OraSure Technologies

    • Figure Sales and Growth Rate Analysis of OraSure Technologies

    • Figure Revenue and Market Share Analysis of OraSure Technologies

    • Table Product and Service Introduction of OraSure Technologies

    • Table Company Profile and Development Status of Calypte Biomedical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calypte Biomedical

    • Figure Sales and Growth Rate Analysis of Calypte Biomedical

    • Figure Revenue and Market Share Analysis of Calypte Biomedical

    • Table Product and Service Introduction of Calypte Biomedical

    • Table Company Profile and Development Status of Quidel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quidel

    • Figure Sales and Growth Rate Analysis of Quidel

    • Figure Revenue and Market Share Analysis of Quidel

    • Table Product and Service Introduction of Quidel

    • Table Company Profile and Development Status of Meridian Bioscience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meridian Bioscience

    • Figure Sales and Growth Rate Analysis of Meridian Bioscience

    • Figure Revenue and Market Share Analysis of Meridian Bioscience

    • Table Product and Service Introduction of Meridian Bioscience


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.